Galvin Gaustad & Stein’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$352K Sell
1,580
-2
-0.1% -$465 0.03% 202
2026
Q2
$376K Buy
+1,582
New +$329K 0.03% 211
2024
Q2
– Sell
-2,228
Closed -$249K – 185
2024
Q1
$249K Sell
2,228
-191
-8% -$20.6K 0.02% 161
2023
Q4
$244K Buy
+2,419
New +$240K 0.02% 166

Other funds holding CAH

Galvin Gaustad & Stein's CAH Position: Q3 2026 in Review

Galvin Gaustad & Stein reduced its Cardinal Health (CAH) stake by 0.13% in Q3 2026, selling an estimated $465 and leaving 1,580 shares worth $352K. The position accounts for 0.03% of the portfolio, ranked #202.

Galvin Gaustad & Stein first reported a position in CAH in Q4 2023 and has held it in 4 quarters since. The position peaked at $376K in Q2 2026. 52 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Galvin Gaustad & Stein held 1,580 shares of Cardinal Health worth $352K as of Q3 2026.
  • Galvin Gaustad & Stein sold 2 Cardinal Health shares in Q3 2026, an estimated $465.
  • Cardinal Health made up 0.03% of Galvin Gaustad & Stein's portfolio in Q3 2026, its #202 holding.
  • Galvin Gaustad & Stein first reported a position in Cardinal Health in Q4 2023 and has held it in 4 quarters since.
  • Galvin Gaustad & Stein's Cardinal Health position peaked at $376K in Q2 2026.
  • 52 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Galvin Gaustad & Stein's 13F filing for Q3 2026, filed 8 Oct 2026.